Want to see SVA full AI Analyst Report?
Compare Sinovac Biotech (SVA) vs. Competitors
Comparison Results
| Name | Price | Market Cap | P/E Ratio | Yearly Gain | Analyst Consensus | Analyst Price Target | Compare | Top Analysts' Price Target | Smart Score | Follow |
|---|---|---|---|---|---|---|---|---|---|---|
| SVASinovac Biotech | $6.47 | $460.27M | -7.79 | 0.00% | ― | SVA | ||||
| SCYXSCYNEXIS | $3.77 | $37.51M | -2.05 | -31.40% | Moderate Buy | SVA vs SCYX | ||||
| KNSAKiniksa Pharmaceuticals | $92.24 | $7.25B | 64.50 | 147.36% | Strong Buy | SVA vs KNSA | ||||
| NSRXNasus Pharma Ltd. | $3.07 | $35.95M | -2.99 | -60.54% | ― | SVA vs NSRX | ||||
| CUVLClinuvel Pharmaceuticals Limited Sponsored ADR | $5.07 | $256.22M | 11.03 | -31.00% | ― | SVA vs CUVL | ||||
| ETRAElectra Therapeutics Inc. | $8.10 | $508.41M | ― | -38.87% | Strong Buy | SVA vs ETRA |
Performance Comparison
| Ticker | Company Name | Price | Change | % Change | |
|---|---|---|---|---|---|
| SVA | Sinovac Biotech | 6.47 | 0.00 | 0.00% | |
| SCYX | SCYNEXIS | 3.77 | -1.34 | -26.21% | |
| KNSA | Kiniksa Pharmaceuticals | 92.24 | 54.77 | 146.17% | |
| NSRX | Nasus Pharma Ltd. | 3.07 | -4.54 | -59.66% | |
| CUVL | Clinuvel Pharmaceuticals Limited Sponsored ADR | 5.07 | -2.28 | -31.01% | |
| ETRA | Electra Therapeutics Inc. | 8.10 | -5.15 | -38.87% |
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts